Sort by
Keyphrases
Survivin
100%
Novel Therapeutics
100%
Pediatric Leukemia
100%
YM155
100%
Sepantronium Bromide
100%
Acute Myeloid Leukemia
50%
Apoptosis
25%
MRNA Expression
12%
DNA Damage
12%
Effective Treatment
12%
Cell Division
12%
Cell Proliferation
12%
Protein Expression
12%
Solid Cancer
12%
Chemotherapy
12%
Bone Marrow Samples
12%
Leukemia
12%
Cell Apoptosis
12%
Concentration-dependent
12%
Poor Clinical Outcomes
12%
Cell Viability
12%
Life Cycle Analysis
12%
High-level Expression
12%
Protein Induction
12%
Therapeutic Strategies
12%
Mechanism of Action
12%
Acute Myeloid Leukemia Cells
12%
Survivin mRNA
12%
Survivin Protein
12%
Clinical Activity
12%
Pediatric Diseases
12%
Annexin V
12%
All Pediatric
12%
Preclinical Evaluation
12%
Acute Myeloid Leukemia Relapse
12%
IC50
12%
Leukemia Cell Lines
12%
Inhibitor of Apoptosis Proteins
12%
Survivin Suppressant
12%
Diagnostic Bones
12%
Medicine and Dentistry
Pediatric Acute Myeloid Leukemia
100%
Sepantronium Bromide
100%
Survivin
100%
Acute Myeloid Leukemia
50%
Programmed Cell Death
30%
DNA Damage
10%
Clinical Trial
10%
Cancer
10%
Pediatrics
10%
Downregulation
10%
Protein Expression
10%
Cell Line
10%
Cell Viability
10%
Cell-Cycle Analysis
10%
Protein Induction
10%
Leukemia
10%
Pediatric Disease
10%
Lipocortin 5
10%
Leukemia Relapse
10%
Cell Division
10%
IC50
10%
Inhibitor of Apoptosis Protein
10%
Acute Myeloid Leukemia Cell Line
10%
Messenger RNA
10%
Effective Treatment
10%
Pharmacology, Toxicology and Pharmaceutical Science
Survivin
100%
Acute Myeloid Leukemia
100%
Sepantronium Bromide
100%
Clinical Trial
10%
Chemotherapy
10%
Leukemia
10%
Cell Viability
10%
IC50
10%
Lipocortin 5
10%
Inhibitor of Apoptosis Protein
10%
Leukemia Relapse
10%
Messenger RNA
10%
Diseases
10%
Cell-Cycle Analysis
10%